Absolok® pilot clinical trial

Absolok® haemostatic evaluation in colorectal surgery: a single-centre randomized open-label pilot clinical trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN79285407

Enrollment

200

Registered

2026-02-05

Start date

2023-09-26

Completion date

Unknown

Last updated

2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haemostatic performance at the transection site for each clipped vessel during curative colorectal resection. Surgery

Interventions

Type of study Monocentric randomized open-label pilot clinical trial. All patients undergoing colorectal resections (namely, right hemicolectomies, left hemicolectomies and rectal resections) will be

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: All >18 years patients undergoing curative colorectal resection for benign and malignant disease, including right hemicolectomies, left hemicolectomies and rectal resections

Exclusion criteria

Exclusion criteria: 1. Patients aged < 18 years 2. Inability to give informed consent 3. Emergent surgery 4. Previous colorectal surgery 5. Uncontrollable diabetes mellitus that needs continuous intravenously administered insulin 6. History of myocardial infarction or unstable angina pectoris within 6 months 7. Cardiac failure, New York Heart Association (NYHA) III degree 8. Anticoagulant therapy 9. Liver cirrhosis, Child-Pugh class C 10. Active hepatitis 11. Chronic renal failure requiring hemodialysis

Countries

Italy

Contacts

Public ContactVincenzo;Sergio Tondolo;Alfieri

;

vincenzo.tondolo@fbf-isola.it;sergio.alfieri@fbf-isola.it+39 06 68371;+39 06 68371

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 19, 2026